Inhibitor-resistant TEM (IRT) β-lactamases with different substitutions at position 244

Antimicrobial Agents and Chemotherapy

Volumn 41, Issue 11, 1997, Pages 2547-2549

  Bret, L ^a   Chaibi, E B ^b   Chanal Claris, C ^a   Sirot, D ^a   Labia, R ^c   Sirot, J ^a  

^a UNIVERSITÉ CLERMONT AUVERGNE   (France)

^b MUSÉUM NATIONAL D'HISTOIRE NATURELLE   (France)

^c CNRS MNHN   (France)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; AMOXICILLIN PLUS CLAVULANIC ACID; ANTIBIOTIC AGENT; BETA LACTAM ANTIBIOTIC; BETA LACTAMASE; CEFALOTIN; CEPHALOSPORIN DERIVATIVE; PENICILLIN G; PIPERACILLIN; SULBACTAM; TAZOBACTAM; TICARCILLIN; TIMENTIN;

AMINO ACID SUBSTITUTION; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIUM ISOLATION; BACTERIUM MUTANT; ESCHERICHIA COLI; GRAM NEGATIVE BACTERIUM; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL;

EID: 0030716482     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/aac.41.11.2547     Document Type: Article

References (23)

1. Ambler, R. P., A. F. W. Coulson, J. M. Frere, J. M. Ghuysen, B. Joris, M. Forsman, R. C. Levesque, G. Tiraby, and S. G. Waley. 1991. A standard numbering scheme for the class A β-lactamases. Biochem. J. 276:269-272.
2. Belaaouaj, A., C. Lapoumeroulie, M. M. Canica, G. Vedel, P. Nevot, R. Krishnamoorthy, and G. Paul. 1994. Nucleotide sequences of the genes coding for the TEM-like β-lactamases IRT-1 and IRT-2 (formerly called TRI-1 and TRI-2). FEMS Microbiol. Lett. 120:75-80.
3. Blazquez, J., M. R. Baquero, R. Canton, I. Alos, and F. Baquero. 1993. Characterization of a new TEM-type β-lactamase resistant to clavulanate, sulbactam, and tazobactam in a clinical isolate of Escherichia coli. Antimicrob. Agents Chemother. 37:2059-2063.
4. Bret, L., C. Chanal, D. Sirot, R. Labia, and J. Sirot. 1996. Characterization of an inhibitor-resistant enzyme IRT-2 derived from TEM-2 β-lactamase produced by Proteus mirabilis strains. J. Antimicrob. Chemother. 38:183-191.
5. Brun, T., J. Peduzzi, M. M. Canica, G. Paul, P. Nevot, M. Barthelemy, and R. Labia. 1994. Characterization and amino acid sequence of IRT-4, a novel TEM-type enzyme with a decreased susceptibility to β-lactamase inhibitors. FEMS Microbiol. Lett. 120:111-118.
6. Chanal, C., M. C. Poupart, D. Sirot, R. Labia, J. Sirot, and R. Cluzel. 1992. Nucleotide sequences of CAZ-2, CAZ-6, and CAZ-7 β-lactamase genes. Antimicrob. Agents Chemother. 36:1817-1820.
7. Delaire, M., R. Labia, J. P. Samama, and J. M. Masson. 1992. Site-directed mutagenesis at the active site of Escherichia coli TEM-1 β-lactamase. J. Biol. Chem. 269:20600-20606.
8. Goussard, S., and P. Courvalin. 1991. Sequence of the genes blaT-1B and blaT-2. Gene 102:71-73.
9. Henquell, C., D. Sirot, C. Chanal, C. De Champs, P. Chatron, B. Lafeuille, P. Texier, J. Sirot, and R. Cluzel. 1994. Frequency of inhibitor-resistant TEM β-lactamases in Escherichia coli isolates from urinary tract infections in France. J. Antimicrob. Chemother. 34:707-714.
10. Henquell, C., C. Chanal, D. Sirot, R. Labia, and J. Sirot. 1995. Molecular characterization of nine different types of mutants among 107 inhibitor-resistant TEM β-lactamases from clinical isolates of Escherichia coli. Antimicrob. Agents Chemother. 39:427-430.
11. Imtiaz, U., E. Billings, J. R. Knox, E. K. Manavathu, S. A. Lerner, and S. Mobashery. 1993. Inactivation of class A β-lactamases by clavulanic acid: the role of arginine 244 in a proposed nonconcerted sequence of events. J. Am. Chem. Soc. 115:4435-4442.
12. Jelsch, C., F. Lenfant, J. M. Masson, and J. P. Samama. 1992. β-Lactamase TEM-1 of Escherichia coli. Crystal structure determination at 2.5 Å resolution. FEBS Lett. 299:135-142.
13. Labia, R., J. Andrillon, and F. Legoffic. 1973. Computerized microacidimetric determination of β-lactamase Michaelis-Menten constants. FEBS Lett. 33:42-44.
14. Lemozy, J., D. Sirot, C. Chanal, C. Huc, R. Labia, H. Dabernat, and J. Sirot. 1995. First characterization of inhibitor-resistant TEM (IRT) β-lactamases in Klebsiella pneumoniae strains. Antimicrob. Agents Chemother. 39:2580-2582.
15. Manavathu, E. K., S. A. Lerner, T. Fekete, M. H. Perlin, E. Ziaja, and S. Price. 1990. Characterization of a mutant TEM β-lactamase that confers resistance to ampicillin (amp) plus clavulanic acid (CA), abstr. 281, p. 133. In Program and abstracts of the 30th Interscience Conference on Antimicrobial Agents and Chemotherapy. American Society for Microbiology, Washington, D.C.
16. Martinez, J. L., M. F. Vicente, A. Delgado-Iribarren, J. C. Perez-Diaz, and F. Baquero. 1989. Small plasmids are involved in amoxicillin-clavulante resistance in Escherichia coli. Antimicrob. Agents Chemother. 33:595.
17. Reguera, J. A., F. Baquero, J. C. Perez-Diaz, and J. L. Martinez. 1991. Factors determining resistance to β-lactam combined with β-lactamase inhibitors in Escherichia coli. J. Antimicrob. Chemother. 27:569-575.
18. Sirot, D., C. Chanal, C. Henquell, R. Labia, J. Sirot, and R. Cluzel. 1994. Clinical isolates of Escherichia coli producing multiple TEM-mutants resistant to β-lactamase inhibitors. J. Antimicrob. Chemother. 33:1117-1126.
19. Stapleton, P., P. J. Wu, A. King, K. Shannon, G. French, and I. Phillips. 1995. Incidence and mechanisms of resistance to the combination of amoxicillin and clavulanic acid in Escherichia coli. Antimicrob. Agents Chemother. 39:2478-2483.
20. Sutcliffe, J. G. 1978. Nucleotide sequence of the ampicillin resistance gene of Escherichia coli plasmid pBR322. Proc. Natl. Acad. Sci. USA 75:3737-3741.
21. Vedel, G., A. Belaaouaj, L. Gilly, R. Labia, A. Philippon, P. Nevot, and G. Paul. 1992. Clinical isolates of Escherichia coli producing TRI β-lactamases: novel TEM-enzymes conferring resistance to β-lactamase inhibitors. J. Antimicrob. Chemother. 30:449-462.
22. Wu, P. J., K. S. Shannon, and I. Phillips. 1994. Effect of hyperproduction of TEM-1 β-lactamase on in vitro susceptibility of Escherichia coli to β-lactam antibiotics. Antimicrob. Agents Chemother. 38:494-498.
23. Zhou, X. Y., F. Bordon, D. Sirot, M.-D. Kitzis, and L. Gutmann. 1994. Emergence of clinical isolates of Escherichia coli producing TEM-1 derivatives or an OXA-1 β-lactamase conferring resistance to β-lactamase inhibitors. Antimicrob. Agents Chemother. 38:1085-1089.